As part of the transaction, the manufacturing operations, sterilization services, warehouse facilities, R&D and regulatory support functions located in Gargrave have been transferred to Scapa Healthcare.
October 8, 2018
Scapa Healthcare recently announced it has completed the acquisition of the Systagenix manufacturing facility located in Gargrave, England.